ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1769

Abdominal Visceral Adipose Tissue Measured By DXA As a Novel Surrogate Marker of Cardiovascular Risk in Primary Necrotizing Vasculitides

Bertrand Dunogué1, Karine Briot2, Sami Kolta3, Alexis Regent4, Pascal Cohen5, Alice Berezne6, Xavier Puéchal5, Claire Le Jeunne5, Luc Mouthon5, Christian Roux7, Loïc Guillevin for the French Vasculitis Study Group5 and Benjamin Terrier8, 1Internal Medicine, Hôpital Cochin, Paris, France, 2Cochin Hospital, Paris Descartes University, Paris, France, 3Rheumatology B, Paris Descartes University, Cochin hospital, Paris, France, 4Internal Medicine, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université Paris Descartes, Paris, France, Paris, France, 5National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 6Paris Descartes University, Internal Medicine department, Cochin Hospital, Paris, France, 7Paris Descartes University, Cochin Hospital, Paris, France, 8National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: adipose tissue, Cardiovascular disease, risk and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Studies have shown a strong prevalence of cardiovascular events among patients with primary necrotizing vasculitides. Recent studies indicate that visceral adipose tissue (VAT) is highly associated with insulin resistance and cardiovascular events. Dual energy X-ray absorptiometry (DXA) is a validated technique able to accurately determine cross-sectionally the mass of discreet fat deposits.

Objective. To assess the relevance of abdominal adipose tissue measurement as potential surrogate markers for cardiovascular risk in patients with primary necrotizing vasculitides.

Methods

Patients with ANCA-associated vasculitides (AAN) and polyarteritis nodosa (PAN) seen in our department were prospectively included in an ongoing cross-sectional study assessing cardio-vascular complications and other sequelae (OSTEOVAS cohort). Alongside the evaluation of usual clinical and extra-clinical features associated with increased cardiovascular risk, DXA was performed to evaluate body composition and abdominal adipose tissue (subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). 

Results

Sixty-five patients were analyzed (38 females, mean age 50±18 years, mean disease duration of 85±79 months). Diagnoses were granulomatosis with polyangiitis (GPA) in 33 patients, microscopic polyangiitis in 6, eosinophilic GPA in 18, and PAN in 8. Five (7.7%) patients had developed cardiovascular complications. The median daily dose of corticosteroid was 5 mg/day (0-80). High cardiovascular risk defined by the NCEP-ATPIII was found in 11 (16.9%) patients. Using univariate analysis, cumulated dose of corticosteroids (p=0.038), Vascular Damage Index (VDI) (p=0.008), and VAT/SAT ratio (p=0.009) were significantly associated with high cardiovascular risk. Using multivariate analysis, VAT/SAT ratio remained independently associated with high-risk status [OR 1.07 (1.03-1.12), p=0.004]. VAT/SAT ratio was also independently correlated with an increased Framingham cardiovascular risk score (p<0.01).

Among factors correlated with a higher VAT/SAT ratio, we identified male gender (p<0.0001), age (r=+0.31, p=0.014), cumulated corticosteroid dose (r=+0.26, p=0.048), VDI score (r=+0.26, p=0.04), Body Mass Index (r=+0.35, p=0.006), waist circumference (r=+0.56, p<0.0001), and elevated troponin levels at time of assessment (r=+0.36, p=0.007). 

Conclusion

This is the first study showing a significant association between a high VAT/SAT ratio assessed by DXA and cardiovascular risk in patients with primary necrotizing vasculitides. Abdominal adipose tissue seems to be an accurate and independent surrogate marker of cardiovascular risk in these patients.


Disclosure:

B. Dunogué,
None;

K. Briot,
None;

S. Kolta,
None;

A. Regent,
None;

P. Cohen,
None;

A. Berezne,
None;

X. Puéchal,
None;

C. Le Jeunne,
None;

L. Mouthon,
None;

C. Roux,
None;

L. Guillevin for the French Vasculitis Study Group,
None;

B. Terrier,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abdominal-visceral-adipose-tissue-measured-by-dxa-as-a-novel-surrogate-marker-of-cardiovascular-risk-in-primary-necrotizing-vasculitides/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology